Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells
- PMID: 33305893
- PMCID: PMC7812255
- DOI: 10.1111/jcmm.16113
Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells
Abstract
Apoptin can specifically kill cancer cells but has no toxicity to normal cells. Human telomerase reverse transcriptase (hTERT) can act as a tumour-specific promoter by triggering the expression of certain genes in tumour cells. This study aims to investigate the inhibitory effects and to explore the inhibitory pathway of a dual cancer-specific recombinant adenovirus (Ad-apoptin-hTERTp-E1a, Ad-VT) on breast cancer stem cells. Breast cancer cell spheres were obtained from MCF-7 cells through serum-free suspension culture. The cell spheres were detected by flow cytometry for CD44+ CD24- cell subsets. The stemness of MCF-7-CSC cells was confirmed by in vivo tumorigenesis experiments. The inhibitory effect of the recombinant adenoviruses on MCF-7-CSC cells was evaluated by CCK-8 assay. In addition, the stemness of adenovirus-infected MCF-7-CSC cells was analysed by testing the presence of CD44+ CD24- cell subsets. The ability of the recombinant adenovirus to induce MCF-7-CSC cell apoptosis was detected by staining JC-1, TMRM and Annexin V. Our results showed that a significantly higher proportion of the CD44+ CD24- cell subsets was present in MCF-7-CSC cells with a significantly increased expression of stem cell marker proteins. The MCF-7-CSC cells, whlist exhibited a strong tumorigenic ability with a certain degree of stemness in mice, were shown to be strongly inhibited by recombinant adenovirus Ad-VT through cell apoptosis. In addition, Ad-VT was shown to exert a killing effect on BCSCs. These results provide a new theoretical basis for the future treatment of breast cancer.
Keywords: apoptin; apoptosis; breast cancer stem cells; recombinant adenovirus.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The research was conducted in the absence of any commercial or financial relationships that could be deemed as a potential conflict of interest.
Figures





Similar articles
-
Effect of bispecific recombinant oncolytic adenovirus carrying apoptin on apoptosis of MCF-7 cells.Front Immunol. 2025 May 16;16:1530583. doi: 10.3389/fimmu.2025.1530583. eCollection 2025. Front Immunol. 2025. PMID: 40453070 Free PMC article.
-
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.BMC Cancer. 2010 Aug 6;10:411. doi: 10.1186/1471-2407-10-411. BMC Cancer. 2010. PMID: 20691079 Free PMC article.
-
Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells.Exp Cell Res. 2020 Nov 1;396(1):112185. doi: 10.1016/j.yexcr.2020.112185. Epub 2020 Aug 20. Exp Cell Res. 2020. PMID: 32828827
-
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.Clin Dev Immunol. 2012;2012:708036. doi: 10.1155/2012/708036. Epub 2012 May 30. Clin Dev Immunol. 2012. PMID: 22693526 Free PMC article. Review.
-
A review of the racial heterogeneity of breast cancer stem cells.Gene. 2021 Sep 5;796-797:145805. doi: 10.1016/j.gene.2021.145805. Epub 2021 Jun 29. Gene. 2021. PMID: 34197949 Review.
Cited by
-
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances.Viruses. 2021 Jun 11;13(6):1128. doi: 10.3390/v13061128. Viruses. 2021. PMID: 34208264 Free PMC article. Review.
-
The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells.Cancer Cell Int. 2023 Oct 25;23(1):250. doi: 10.1186/s12935-023-03099-y. Cancer Cell Int. 2023. PMID: 37880659 Free PMC article. Review.
-
Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells.Viruses. 2024 Apr 5;16(4):567. doi: 10.3390/v16040567. Viruses. 2024. PMID: 38675909 Free PMC article.
-
Suspension culture strategies to enrich colon cancer stem cells.Oncol Lett. 2023 Feb 6;25(3):116. doi: 10.3892/ol.2023.13702. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36844615 Free PMC article.
-
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways.Transl Oncol. 2024 Oct;48:102067. doi: 10.1016/j.tranon.2024.102067. Epub 2024 Aug 1. Transl Oncol. 2024. PMID: 39094512 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57‐70. - PubMed
-
- Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275‐291. - PubMed
-
- Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730‐737. - PubMed
-
- Valent P, Bonnet D, De Maria R, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12:767‐775. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous